Could Nodal RT Explain Failure of ICIs in Head and Neck Cancer?
Immune checkpoint inhibitors (ICIs) have shown impressive efficacy in many different cancer types, but not in head and neck cancer: could nodal irradiation blunt the immune response?
Stay updated with breaking news from Sentinel Lymph Node. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Immune checkpoint inhibitors (ICIs) have shown impressive efficacy in many different cancer types, but not in head and neck cancer: could nodal irradiation blunt the immune response?
Share this article Share this article ResearchAndMarkets.com's offering. The market for breast lesion localization methods is expected to grow from 3,974.4 thousands of procedures in 2020 to 5750.9 thousands of procedures by 2025, at a CAGR of 7.5% during the forecast period. The breast lesion localization methods market is driven primarily by the increasing incidence of breast cancer, rising number of breast cancer surgeries, and growing awareness on the early detection of breast cancer. However, uncertainty in regulatory approval procedures is expected to restrain the growth of this marke...